Goldfarb Neil, Weston Christine, Hartmann Christine W, Sikirica Mirko, Crawford Albert, He Hope, Howell Jamie, Maio Vittorio, Clarke Janice, Nuthulaganti Bhaskar, Cobb Nicole
Department of Helath Policy, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.
Dis Manag. 2004 Spring;7(1):61-75. doi: 10.1089/109350704322919005.
This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions - asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a cornerstone of disease management.
本文介绍了一项文献综述的结果，该综述调查了适当药物治疗对四种常见慢性病（哮喘、糖尿病、心力衰竭和偏头痛）的经济影响。该综述的目的是确定高质量的研究，以检验适当药物治疗对总体医疗支出（直接成本）和工作场所生产力（间接成本）的影响程度。进行该综述的工作假设是，所选慢性病的药物成本被其他领域直接和间接成本的节省所抵消。文献表明，适当的药物治疗可改善慢性病患者的健康状况和生活质量，同时降低与急诊室、住院及其他医疗服务使用相关的成本。越来越多的证据还表明，慢性病通过药物得到有效控制的工人生产力更高。对雇主而言，这些证据意味着潜在的直接和间接成本节省。研究结果还证实了药物管理作为疾病管理基石的重要性。
